MRKR (STOCKS)
Marker Therapeutics, Inc. Common Stock
$1.440000
-0.020000 (-1.37%)
Prev close: $1.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Juan F. Vera
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $23.84M
- Employees
- 5
- P/E (TTM)
- -1.17
- P/B (TTM)
- 1.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.12 | $-0.46 | +0.3390 | +73.86% |
|
Jun 2025 (Q2)
|
$-0.29 | $-0.42 | +0.1282 | +30.66% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.50 | +0.1403 | +28.04% |
|
Dec 2024 (Q4)
|
$-0.42 | $-0.22 | -0.1961 | -87.58% |
Financial Statements
| Revenues | $4.69M |
| Benefits Costs and Expenses | $10.83M |
| Costs And Expenses | $19.08M |
| Operating Expenses | $19.56M |
| Research and Development | $14.74M |
| Other Operating Expenses | $4.82M |
| Operating Income/Loss | -$14.87M |
| Income/Loss From Continuing Operations After Tax | -$14.30M |
| Income/Loss From Continuing Operations Before Tax | -$11.02M |
| Net Income/Loss | -$14.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$14.30M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.17 |
| Diluted Earnings Per Share | -$1.17 |
| Basic Average Shares | 14,026,511 |
| Diluted Average Shares | 14,026,511 |
| Assets | $21.73M |
| Current Assets | $21.73M |
| Noncurrent Assets | $0.00 |
| Liabilities | $3.35M |
| Current Liabilities | $3.35M |
| Accounts Payable | $951.00K |
| Wages | $49.00K |
| Other Current Liabilities | $2.35M |
| Noncurrent Liabilities | $0.00 |
| Equity | $18.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $18.39M |
| Liabilities And Equity | $21.73M |
| Net Cash Flow From Operating Activities | -$14.82M |
| Net Cash Flow From Operating Activities, Continuing | -$14.82M |
| Net Cash Flow From Investing Activities | -$9.94M |
| Net Cash Flow From Investing Activities, Continuing | -$9.94M |
| Net Cash Flow From Financing Activities | $24.76M |
| Net Cash Flow From Financing Activities, Continuing | $24.76M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$14.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$14.30M |
| Other Comprehensive Income/Loss | $0.00 |